dose 3: Clinical Trials

6 trials of dose 3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 active not recruiting, 1 recruiting. 3 Phase 1, 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Active not recruiting 1
Not applicable2Completed 1, Recruiting 1
Phase 41Completed 1

Follow dose 3: new trials by email Literature Review of dose 3 trials Research Report on dose 3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability and Pharmacokinetics of ETD-001 Gel
Dose 1, dose 2, dose 3 - Safety Issues
Phase 1CompletedEtern Therapeutics Wuxi Limited562026-03-162026-09-10
Reach Through Equitable Implementation in Utah
Clinic Level: AAC - SDOH, AAC - Tobacco, Non-Bundled, Bundled - Tobacco Use Cessation, Tobacco Use
Not applicableRecruitingUniversity of Utah15602025-02-132025-03-18
Perioperative Methadone in Hip Fracture Patients
Methadone (Dose1), Methadone (Dose 2), Methadone (Dose 3) - Methadone, Pain, Post Operative
Phase 4CompletedUniversity of Southern Denmark312023-01-122023-04-18
Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)
Dose 1, Dose 2, Dose 0 - Diabetes Prevention
Phase 1CompletedPennington Biomedical Research Center642014-02-012019-03-21
Transfer of Genetically Engineered Lymphocytes in Melanoma Patients
Dose 1, Dose 2, Dose 3 - Melanoma
Phase 1Active not recruitingLoyola University142012-07-012020-10-30
A Study of Strawberries and Disease Risk
Placebo, 10G, 20G - Nutritional and Metabolic Diseases, Inflammation
Not applicableCompletedClinical Nutrition Research Center, Illinois Institute of Technology292010-09-152021-02-12

Conditions studied

Inflammation (1)  ·  Insulin Resistance (1)  ·  Melanoma (1)  ·  Metabolic Syndrome (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pain, Postoperative (1)  ·  Tobacco Smoking (1)  ·  Tobacco Use (1)  ·  Tobacco Use Cessation (1)  ·  Tobacco Use Disorder (1)

Sponsors

Clinical Nutrition Research Center, Illinois Institute of Technology (1)  ·  Etern Therapeutics Wuxi Limited (1)  ·  Loyola University (1)  ·  Pennington Biomedical Research Center (1)  ·  University of Southern Denmark (1)  ·  University of Utah (1)

Countries

United States (4)  ·  China (1)  ·  Denmark (1)

Top investigators

Britt Burton-Freeman, PhD, MS (1)  ·  Chelsey Schlechter, MPH, PhD (1)  ·  Indika Edirisinghe, PhD (1)  ·  Jennifer C Rood, Ph.D. (1)  ·  Michael Nishimura, PhD (1)

Results publications

PMID 26842771, PMID 38047142

NIH funding

P01CA154778 (1), P50AT002776 (1), R44CA126461 (1), U54CA280812 (1)